Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Frazier Healthcare Partners
Biotech
AirNexis swoops in with $200M series A for COPD asset
AirNexis has inked a deal potentially worth almost $1 billion with a China biopharma, securing rights to a clinical-stage COPD asset.
Gabrielle Masson
Jan 9, 2026 11:01am
Frazier Life Sciences gathers $630M for small, mid-cap biotechs
Oct 2, 2024 9:30am
SunMed nabs airway consumables catalog from Vyaire Medical
Mar 28, 2023 10:53am
Frazier's $987M fund geared toward new startups, spin outs
Mar 16, 2022 5:00am
Frazier raises $830M for first public life science fund
Oct 28, 2021 8:00am
Crinetics creates Radionetics with $30M for 10 cancer candidates
Oct 18, 2021 4:14pm
